Gpx1 — Glutathione Peroxidase 1 is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
| GPX1 — Glutathione Peroxidase 1 | |
|---|---|
| Symbol | GPX1 |
| Full Name | Glutathione Peroxidase 1 |
| Chromosome | 3p21.31 |
| NCBI Gene | 2783 |
| Ensembl | ENSG00000133247 |
| OMIM | 138320 |
| UniProt | P07203 |
| Diseases | Parkinson's Disease, Alzheimer's Disease, Stroke, Cardiovascular Disease |
| Expression | Liver, Kidney, Heart, Brain, Erythrocytes |
GPX1 (Glutathione Peroxidase 1) is a gene located on chromosome 3p21.31 that encodes a selenoprotein enzyme crucial for cellular antioxidant defense. GPX1 catalyzes the reduction of hydrogen peroxide and organic hydroperoxides to water and corresponding alcohols, using glutathione as the electron donor.
GPX1 is one of the most abundant selenoproteins in mammals and plays a central role in protecting cells from oxidative damage:
The enzyme operates in the cytosol and mitochondria, providing broad antioxidant protection throughout the cell.
Parkinson's Disease: GPX1 activity is reduced in the substantia nigra of PD patients. Genetic variants may influence disease risk.
Alzheimer's Disease: GPX1 expression is altered in AD brain tissue. The enzyme may protect against amyloid-beta induced oxidative damage.
Stroke: GPX1 provides neuroprotection against ischemic injury.
ALS: Altered GPX activity has been reported in ALS models and patients.
The study of Gpx1 — Glutathione Peroxidase 1 has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.